Alexander A. Seelenberger - May 23, 2024 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Financial Officer
Signature
By: /s/ Dr. Ahmed M. Hamdy, attorney-in-fact
Stock symbol
VINC
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/29/2024, 09:12 PM
Previous filing
Mar 8, 2024
Next filing
Aug 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +31.3K +33.33% $0.00 125K May 23, 2024 Common Stock 31.3K $7.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024.
F2 One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.